XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Statement of Cash Flows [Abstract]    
Net loss $ (10,115) $ (7,476)
Adjustment to reconcile net loss to net cash:    
Depreciation and amortization 473 504
Common stock-based compensation and expenses, net 1,433 2,260
Impairment of assets 3,358 0
Other non-cash items (42) 39
Changes in:    
Accounts receivables, net 14 (127)
Inventory (8) (200)
Deposits and advances 169 656
Claims and advances 4 (91)
Accounts payable 117 (516)
Accrued and other liabilities (83) (572)
Operating lease asset 99 93
Operating lease liability (92) (100)
Net cash used in operating activities (4,673) (5,530)
Cash flow from investing activities:    
Purchase of property, plant, and equipment (123) (305)
Sale of property, plant, and equipment 42 544
Investment in short term investments 154 (88)
Acquisition and filing cost of patents and rights (67) (144)
Net cash provided by investing activities 6 7
Cash flows from financing activities:    
Net proceeds from the issuance of common stock 2,860 103
Repayment of long-term loan (3) (2)
Net cash provided by financing activities 2,857 101
Effects of exchange rate changes on cash and cash equivalents (8) (93)
Net decrease in cash and cash equivalents (1,818) (5,515)
Cash and cash equivalents at the beginning of the period 3,196 10,460
Cash and cash equivalents at the end of the period 1,378 4,945
Non-cash items:    
Common stock issued/granted for stock-based compensation, including patent acquisition $ 1,433 $ 2,260